Shionogi Sustainability Profile
Shionogi & Co., Ltd., commonly known as Shionogi, is a prominent pharmaceutical company headquartered in Osaka, Japan. Founded in 1878, Shionogi has established itself as a leader in the pharmaceutical industry, focusing on research and development in areas such as infectious diseases, pain management, and central nervous system disorders. With a strong presence in Japan and expanding operations in North America and Europe, Shionogi is renowned for its innovative core products, including antiviral treatments and analgesics. The company’s commitment to advancing healthcare solutions has led to significant milestones, including the development of groundbreaking therapies that address unmet medical needs. Shionogi's dedication to quality and innovation has positioned it as a key player in the global pharmaceutical market, earning recognition for its contributions to public health and patient care.
DitchCarbon Score
How does Shionogi's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Shionogi's score of 81 is higher than 88% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Shionogi's reported carbon emissions
In 2024, Shionogi & Co., Ltd. reported total carbon emissions of approximately 242,214,000 kg CO2e. This figure includes 40,090,000 kg CO2e from Scope 1 emissions, 22,967,000 kg CO2e from Scope 2 (market-based), and a significant 179,157,000 kg CO2e from Scope 3 emissions. The company has set ambitious targets to reduce its carbon footprint, aiming for a 46.2% reduction in absolute Scope 1 and 2 emissions by 2030, based on 2019 levels, and a 20% reduction in Scope 3 emissions from purchased goods and services by the same year. In 2023, Shionogi's total emissions were approximately 214,942,000 kg CO2e, with Scope 1 emissions at 40,373,000 kg CO2e, Scope 2 emissions at 31,650,000 kg CO2e (market-based), and Scope 3 emissions at 142,919,000 kg CO2e. This indicates a slight increase in total emissions compared to 2024. The company has also committed to achieving net-zero emissions across all scopes by 2050. Specific near-term goals include reducing Scope 1 and 2 emissions to near zero by 2025. Shionogi's targets are aligned with the Science Based Targets initiative (SBTi), ensuring that their reduction strategies are consistent with the global aim to limit warming to 1.5°C. Overall, Shionogi's climate commitments reflect a proactive approach to sustainability within the pharmaceutical sector, with clear targets and a focus on significant emissions reductions in the coming years.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|
| Scope 1 | 43,456,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 |
| Scope 2 | 46,681,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 |
| Scope 3 | 196,761,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 |
How Carbon Intensive is Shionogi's Industry?
How Carbon Intensive is Shionogi's Location?
Shionogi's Scope 3 Categories Breakdown
Shionogi's Scope 3 emissions, which increased by 25% last year and decreased by approximately 9% since 2017, demonstrating supply chain emissions tracking. Most of their carbon footprint comes from suppliers and value chain emissions, with Scope 3 emissions accounting for 74% of total emissions under the GHG Protocol, with "Purchased Goods and Services" being the largest emissions source at 51% of Scope 3 emissions.
Top Scope 3 Categories
Shionogi's Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Shionogi has established climate goals through participation in recognized frameworks and target-setting initiatives. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
Frequently Asked Questions
Common questions about Shionogi's sustainability data and climate commitments